Elsevier / Gold Standard’s Kay Morgan Awarded NCPCP Highest Honor
Morgan honored with The TIME Award for lifetime contributions to NCPDP
Tampa, FL, May 17, 2012 – The National Council for Prescription Drug Programs (NCPDP), a not-for-profit standards organization with more than 1,500 members throughout the pharmacy services industry, awarded Kay Morgan, Senior Vice President of Drug Products and Industry Standards Research and Compliance for Elsevier/Gold Standard, with its highest honor, The TIME Award, last week at its annual conference in Phoenix. Elsevier / Gold Standard is a leading drug information and drug decision support provider.
NCPDP established The TIME (The Individual Member Excellence) Award in 1990. It honors an NCPDP member for unselfish devotion toward meeting the goals and objectives of the organization. For the past 35 years, NCPDP has brought together all parts of the industry – payers, providers and suppliers – to develop business solutions and guidance for promoting information exchanges related to medications, supplies, and services within the healthcare system, to improve safety, privacy and healthcare outcomes for patients, while reducing costs in the system.
The NCPDP Conference Daily quoted from Kay’s TIME nomination: “Kay is consistently and energetically involved in the activities of NCPDP and is an available resource for members to understand, influence and comply with the standards represented by the Council. This membership segment has brought new perspectives to the organization as we continue to address industry challenges. Kay has also represented pharmacy and NCPDP concerns in her interactions with the FDA and others as the groups work together toward industry solutions.”
# # #
Based in Tampa, FL, Elsevier/Gold Standard uses innovative technologies to provide a complete suite of drug information and decision support solutions. With a tenacious commitment to product quality, Elsevier/Gold Standard solutions empower healthcare organizations, professionals and consumers to meet the most pressing healthcare challenges, improve patient safety and ensure optimal outcomes. To learn more about Elsevier/Gold Standard, visit www.goldstandard.com.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
Vice President, Global Corporate Relations, Elsevier
+1 215 239 3508